Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports
Published in: Current Bladder Dysfunction Reports 4/2020

01-12-2020 | Cystitis | Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Urinary Tract Infection and Pelvic Organ Prolapse—an Association that Needs Further Clarification

Authors: Gláucia Miranda Varella Pereira, Luiz Gustavo Oliveira Brito, Paulo Cesar Rodrigues Palma

Published in: Current Bladder Dysfunction Reports | Issue 4/2020

Login to get access

Abstract

Purpose of Review

This review will summarize the latest evidence regarding an association between urinary tract infection and pelvic organ prolapse. Topics include pelvic organ prolapse, urinary tract infection, surgical and conservative interventions for pelvic organ prolapse, and the risk for urinary tract infection, catheterizations, and prophylaxis for urinary tract infection and pelvic organ prolapse.

Recent Findings

Although no studies were found regarding mechanistic factors for the association between UTI and POP, or with the degree/severity of prolapse with the risk for UTI, this review adds critical information from various studies recently published addressing topics which of was not mentioned in previous reviews of a similar theme.

Summary

UTI incidence seems to be increased in POP patients, and reconstructive surgery seems to be connected with the risk of UTI. Future studies exploring mechanistic factors for UTI and POP are needed.
Literature
1.
Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(4):655–84.PubMed
2.
3.
Handa VL, Garrett E, Hendrix S, Gold E, Robbins J. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am J Obstet Gynecol. 2004;190(1):27–32.PubMed
4.
Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160–6.PubMed
5.
Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11):1559–73.PubMedPubMedCentral
6.
Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213–40.PubMed
7.
ACOG. Pelvic organ prolapse: ACOG Practice Bulletin, Number 214. 277 Obstet Gynecol. 2019;134(5):e126–e142.
8.
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.PubMed
9.
Alperin M, Burnett L, Lukacz E, Brubaker L. The mysteries of menopause and urogynecologic health: clinical and scientific gaps. Menopause. 2019;26(1):103–11.PubMedPubMedCentral
10.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–84.PubMedPubMedCentral
11.
Ortega Martell JA, Naber KG, Milhem Haddad J, Tirán Saucedo J, Domínguez Burgos JA. Prevention of recurrent urinary tract infections: bridging the gap between clinical practice and guidelines in Latin America [published correction appears in Ther Adv Urol. 2019 Jul 05;11:1756287219863170]. Ther Adv Urol. 2019;11:1756287218824089.PubMedPubMedCentral
12.
Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, et al. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. J Urol. 2019;202(2):282–9.PubMed
13.
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53–70.PubMed
14.
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin N Am. 2014;28(1):1–13.
15.
Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectrum 2016;4(5):UTI–0002–2012.
16.
Dietz HP. Pelvic organ prolapse - a review. Aust Fam Physician. 2015;44(7):446–52.PubMed
17.
Haylen BT, Lee J, Logan V, Husselbee S, Zhou J, Law M. Immediate postvoid residual volumes in women with symptoms of pelvic floor dysfunction. Obstet Gynecol. 2008;111(6):1305–12.PubMed
18.
Töz E, Kurt S, Sahin Ç, Canda MT. Frequency of recurrent urinary tract infection in patients with pelvic organ prolapse. Res Rep Urol. 2015;7:9–12.PubMedPubMedCentral
19.
Haylen B, Lee J, Husselbee S, Law M, Zhou J. Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(7):837–42.PubMed
20.
Haylen BT, Krishnan S, Schulz S, Verity L, Law M, Zhou J, et al. Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(1):53–6.PubMed
21.
Haya N, Feiner B, Baessler K, Christmann-Schmid C, Maher C. Perioperative interventions in pelvic organ prolapse surgery. Cochrane Database Syst Rev. 2018;8(8):CD013105.PubMed
22.
Dieter AA, Amundsen CL, Edenfield AL, Kawasaki A, Levin PJ, Visco AG, et al. Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial [published correction appears in Obstet Gynecol. 2014 Mar;123(3):669]. Obstet Gynecol. 2014;123(1):96–103.PubMed
23.
Mowat A, Maher D, Baessler K, Christmann-Schmid C, Haya N, Maher C. Surgery for women with posterior compartment prolapse. Cochrane Database Syst Rev. 2018;3(3):CD012975.PubMed
24.
Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev. 2016;10(10):CD012376.PubMed
25.
Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2013, Issue 4. Art. No.: CD004014.
26.
•• Bray R, Cartwright R, Digesu A, Fernando R, Khullar V. A randomised controlled trial comparing immediate versus delayed catheter removal following vaginal prolapse surgery. Eur J Obstet Gynecol Reprod Biol. 2017;210:314–8 This trial showed the role of early catheter removal in the reduction of UTI.PubMed
27.
El-Nashar SA, Singh R, Schmitt JJ, et al. Urinary tract infection after hysterectomy for benign gynecologic conditions or pelvic reconstructive surgery. Obstet Gynecol. 2018;132(6):1347–57.PubMed
28.
Körnig M, Brühlmann E, Günthert A, Christmann C. Intra-, peri- and postoperative complications in pelvic organ prolapse surgery in geriatric women. Eur J Obstet Gynecol Reprod Biol. 2018;224:142–5.PubMed
29.
Krissi H, Aviram A, Ram E, Eitan R, Wiznitzer A, Peled Y. Colpocleisis surgery in women over 80 years old with severe triple compartment pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2015;195:206–9.PubMed
30.
Catanzarite T, Rambachan A, Mueller MG, Pilecki MA, Kim JY, Kenton K. Risk factors for 30-day perioperative complications after Le Fort colpocleisis. J Urol. 2014;192(3):788–92.PubMed
31.
Hill AJ, Walters MD, Unger CA. Perioperative adverse events associated with colpocleisis for uterovaginal and posthysterectomy vaginal vault prolapse. Am J Obstet Gynecol. 2016;214(4):501.e1–6.
32.
Bochenska K, Leader-Cramer A, Mueller M, Davé B, Alverdy A, Kenton K. Perioperative complications following colpocleisis with and without concomitant vaginal hysterectomy. Int Urogynecol J. 2017;28(11):1671–5.PubMed
33.
Sifuentes R, Wolff BJ, Barnes HC, Wozniak A, Mueller ER, Pham TT. You’re how old? Correlating perioperative complication risk in octogenarians undergoing colpocleisis for pelvic organ prolapse [published online ahead of print, 2019 Jul 24]. Female Pelvic Med Reconstr Surg. 2019. https://​doi.​org/​10.​1097/​SPV.​0000000000000759​.
34.
Bretschneider CE, Robinson B, Geller EJ, Wu JM. The effect of age on postoperative morbidity in women undergoing urogynecologic surgery. Female Pelvic Med Reconstr Surg. 2015;21(4):236–40.PubMed
35.
FitzGerald MP, Richter HE, Siddique S, Thompson P, Zyczynski H. Ann Weber for the Pelvic Floor Disorders Network. Colpocleisis: a review. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(3):261–71.PubMed
36.
Geller EJ. Prevention and management of postoperative urinary retention after urogynecologic surgery. Int J Women's Health. 2014;6:829–38.
37.
• Shatkin-Margolis A, Yook E, Hill AM, et al. Self-removal of a urinary catheter after urogynecologic surgery: a randomized controlled trial. Obstet Gynecol. 2019;134(5):1027–36 This trial showed the benefits of catheter self-discontinuation.PubMed
38.
•• Lavelle ES, Alam P, Meister M, et al. Antibiotic prophylaxis during catheter-managed postoperative urinary retention after pelvic reconstructive surgery: a randomized controlled trial [published correction appears in Obstet Gynecol. 2020 Jan;135(1):222]. Obstet Gynecol. 2019;134(4):727-735. The trial compared daily nitrofurantoin prophylaxis with placebo in the reduction of the incidence of culture-proven UTI.
39.
• Boyd SS, OʼSullivan DM, Tunitsky-Bitton E. A comparison of two methods of catheter management after pelvic reconstructive surgery: a randomized controlled trial. Obstet Gynecol. 2019;134(5):1037–45 This trial compared two types of drainage catheters in postoperative activity.PubMed
40.
Thomas-White KJ, Gao X, Lin H, Fok CS, Ghanayem K, Mueller ER, et al. Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients. Int Urogynecol J. 2018;29(12):1797–805.PubMedPubMedCentral
41.
42.
Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625–63.PubMed
43.
Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med. 1991;324(22):1599.PubMed
44.
•• Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015;213(2):194.e1–194.e1948 This trial compared the therapeutic effect of cranberry juice capsules with placebo in preventing UTI after surgery.
45.
Shatkin-Margolis A, Warehime J, Pauls RN. Cranberry supplementation does not reduce urinary tract infections in patients with indwelling catheters after pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg. 2018;24(2):130–4.PubMed
46.
Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD001321 Published 2012 Oct 17.PubMed
47.
Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84.PubMed
48.
• Russo E, Montt Guevara M, Giannini A, et al. Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery. Climacteric. 2020;23(2):201–5 This trial assessed the effect of a supplement on lower urinary tract symptoms.PubMed
Metadata
Title
Urinary Tract Infection and Pelvic Organ Prolapse—an Association that Needs Further Clarification
Authors
Gláucia Miranda Varella Pereira
Luiz Gustavo Oliveira Brito
Paulo Cesar Rodrigues Palma
Publication date
01-12-2020
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports / Issue 4/2020
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-020-00607-y

Other articles of this Issue 4/2020

Current Bladder Dysfunction Reports 4/2020 Go to the issue

Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)

Urodynamics for the “Failed” Midurethral Sling

Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Vaginal Yeast Infection

Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)

Assessing In Vivo Bladder Urothelial Hyper-Permeability: Preclinical and Clinical Implications

Hot Topic

The Necessity of Postoperative Bladder Training by Intermittent Clamping: a Urologist’s View

Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Management of Chronic Bacteriuria in Neurogenic Bladders

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Antibiotic Prophylaxis in Pelvic Floor Surgery